Detalhe da pesquisa
1.
Screening Platform toward New Anti-HIV Aptamers Set on Molecular Docking and Fluorescence Quenching Techniques.
Anal Chem
; 88(4): 2327-34, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26810800
2.
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation.
J Pept Sci
; 21(5): 392-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25694247
3.
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells.
J Oncol
; 2019: 9293560, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31929800
4.
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration.
Eur J Med Chem
; 143: 348-360, 2018 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29202399
5.
The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
Oncotarget
; 7(34): 54474-54487, 2016 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27323409
6.
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.
J Med Chem
; 58(24): 9773-8, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26599352
7.
Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.
PLoS One
; 10(5): e0126172, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25938482
8.
Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
J Med Chem
; 57(14): 5965-74, 2014 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24992374
9.
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
J Exp Clin Cancer Res
; 33: 48, 2014 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24893613